IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ironwood Pharmaceuticals, Inc

Q2 2013 vs Q1 2018

Comparing institutional holders between quarters

Quarters

Q1 2018Q2 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Broderick Brian C
UNCHANGED
Shares55,000 from 55,000
Change0 (0%)
Value$849 (+$303)
Filed 2018-04-24
Status
Broderick Brian C
UNCHANGED55,00055,00000%$546$849+$3032018-04-24
Showing 1 of 1 institutions